903 related articles for article (PubMed ID: 26934863)
1. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
3. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L
Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1.
Lin CW; Chang YL; Chang YC; Lin JC; Chen CC; Pan SH; Wu CT; Chen HY; Yang SC; Hong TM; Yang PC
Nat Commun; 2013; 4():1877. PubMed ID: 23695671
[TBL] [Abstract][Full Text] [Related]
5. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
[TBL] [Abstract][Full Text] [Related]
6. MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway.
Li L; Zhao J; Huang S; Wang Y; Zhu L; Cao Y; Xiong J; Deng J
Gene; 2018 Jan; 641():240-247. PubMed ID: 29045821
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.
Xia Y; Gao Y
Biochem Biophys Res Commun; 2014 May; 447(3):446-51. PubMed ID: 24735543
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of miR-506 inhibits cell growth and disrupt the cell cycle by targeting YAP in breast cancer cells.
Hua K; Yang W; Song H; Song J; Wei C; Li D; Fang L
Int J Clin Exp Med; 2015; 8(8):12018-27. PubMed ID: 26550114
[TBL] [Abstract][Full Text] [Related]
9. MiR-135b is a novel oncogenic factor in cutaneous melanoma by targeting LATS2.
Hu Y; Wang Q; Zhu XH
Melanoma Res; 2019 Apr; 29(2):119-125. PubMed ID: 30480622
[TBL] [Abstract][Full Text] [Related]
10. miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
Li J; Liang H; Bai M; Ning T; Wang C; Fan Q; Wang Y; Fu Z; Wang N; Liu R; Zen K; Zhang CY; Chen X; Ba Y
PLoS One; 2015; 10(6):e0130194. PubMed ID: 26061281
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2.
Song L; Huang Y; Zhang X; Han S; Hou M; Li H
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):32. PubMed ID: 32186675
[TBL] [Abstract][Full Text] [Related]
12. miR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2.
Han LL; Yin XR; Zhang SQ
Int J Oncol; 2018 Dec; 53(6):2433-2444. PubMed ID: 30272278
[TBL] [Abstract][Full Text] [Related]
13. miR-650 Promotes the Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Directly Inhibiting LATS2 Expression.
Han LL; Yin XR; Zhang SQ
Cell Physiol Biochem; 2018; 51(3):1179-1192. PubMed ID: 30481780
[TBL] [Abstract][Full Text] [Related]
14. miR-21: A gene of dual regulation in breast cancer.
Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X
Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
16. miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer.
Wang J; Wang S; Zhou J; Qian Q
Biomed Pharmacother; 2018 Jun; 102():147-152. PubMed ID: 29550638
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.
Xu Y; Zhao S; Cui M; Wang Q
Int J Clin Exp Pathol; 2015; 8(9):10294-304. PubMed ID: 26617737
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of prolactin inhibition of miR-135b via methylation in goat mammary epithelial cells.
Chen Z; Luo J; Zhang C; Ma Y; Sun S; Zhang T; Loor JJ
J Cell Physiol; 2018 Jan; 233(1):651-662. PubMed ID: 28332185
[TBL] [Abstract][Full Text] [Related]
19. miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2.
Zhou J; Tian Y; Li J; Lu B; Sun M; Zou Y; Kong R; Luo Y; Shi Y; Wang K; Ji G
Biochem Biophys Res Commun; 2013 Apr; 433(2):207-12. PubMed ID: 23466356
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of MiR-10b Restrains the Migration and Epithelial-Mesenchymal Transition of Lung Cells by Targeting LATS2 via TAZ Pathway.
Yang Y; Wang J
Med Sci Monit; 2020 May; 26():e920275. PubMed ID: 32361707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
